DOI: http://dx.doi.org/10.18203/2349-2902.isj20213126

Clinical study of prevalence of malignancy in nodular thyroid swelling

Balaji Chittipotula, Rajat Kumar Patra

Abstract


Background: Large proportion of thyroid cancers arose from a pre-existing adenoma or from multinodular goiters. Surgical practice of removing thyroid nodule or multiple nodules of thyroid gland has been challenged for surgeons to prevent cancer. Aim of this study is to find out the prevalence of malignancy in solitary thyroid nodule and multi-nodular goitre in relation to age and sex. The aim of the study was to determine the incidence of malignancy in patients who underwent thyroidectomies.

Methods: Study of 100 cases of nodular thyroid swelling has been done during the period from November 2017 to November 2019 on inpatients admitted to GEMS Hospital, Srikakulam, and Andhra Pradesh, India. Detail clinical examination, relevant investigations, surgical management and histopathological reports were collected and analyzed using software package for statistical analysis (SPSS 20).

Results: Out of 100 patients with thyroid swellings, thyroid malignancies constitute 4%. The occurrence of thyroid cancer was maximum in the 4th decade of life. Female patients outnumbered males with a ratio of 4:0. Relative frequency of malignancy in solitary thyroid nodule was 4.76% and in multi-nodular goitre was 3.03%. Most common histopathological type was papillary carcinoma thyroid (50%); followed by follicular carcinoma thyroid (25%) and medullary carcinoma (25%).

Conclusions: The prevalence of thyroid malignancy in the present study is at an earlier age group due to early diagnosis and treatment. The prevalence of thyroid cancer is higher in female when compared to those reported in the literature.  The proportion of medullary cancer is more in present study.

 


Keywords


Nodular thyroid swelling, Papillary carcinoma thyroid, Follicular carcinoma, Medullary carcinoma

Full Text:

PDF

References


Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-82.

Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am. 2012; 96(2):329-49.

Jena A, Patnayak R, Prakash J, Sachan A, Suresh V, Lakshmi AY. Malignancy in solitary thyroid nodule: A clinicoradiopathological evaluation. Indian J Endocrinol Metab. 2015;19(4):498-503.

Dave RI, Patel DD. Carcinoma of thyroid- A review of 80 cases. Indian J Surg. 1983;656-63.

Bhansali SK, Chibber PC, Deshpande D, Satoskar RS. Management of thyroid carcinoma. Experience with 52 cases. Indian J Surg. 1979;41:665-76.

Rahman MJ, Mustafa MG. Comparative study of cancer developing in Solitary thyroid nodule and multi-nodular goiter. Bangladesh Ototorhinolargygol. 2000;6(11):6-12.

Sattar MA, Alam MR, Haider A. Clinico Pathological study of solitary cold 85 thyroid nodule. Bangladesh J Otorhinolaryngol. 2003;9(1):24-7.

Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69:537-40.

Kwong N, Medici M, Angell TE, Liu X, Marqusee E, Cibas ES, et al. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab. 2015;100:4434-40.

Santos SI, Swerdlow AJ. Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer. 1993;67(2):330-40.

Zuberi LM, Yawar A, Islam N, Jabbar A. Clinical presentation of thyroid cancerpatients in Pakistan--AKUH experience. J Pak Med Assoc. 2004;54(10):526-8.

Holzer S, Reiners C, Mann K, Bamberg M, Rothmund M. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland in Germany during 1996. Cancer. 2000;89(1):192-201.

Kannan RR. Thyroid Cancer- Indian Institutional experience. In: Mishra SK, eds. Monograph on thyroid cancer. Madras. 1997: 153-155.

Mackenzie EJ, Mortiner RH. Thyroid nodules and thyroid Cancer. Med J Australia. 2004;180(5):242-7.

Ergin AB, Saralaya S, Olansky L. Incidental papillary thyroid carcinoma: clinical characteristics and prognostic factors among patients with Graves’ disease and euthyroid goiter, Cleveland Clinic experience. Am J Otolaryngol. 2014;35:784-90.

Smith JJ, Chen X, Schneider DF, Broome JT, Sippel RS, Chen H, et al. Cancer after thyroidectomy: a multi-institutional experience with 1,523 patients. J Am Coll Surg. 2013;216:571-7.

Miccoli P, Minuto MN, Galleri D, Agostino J, Basolo F, Antonangeli L, Lombardi F, et al. Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease. ANZ J Surg. 2006;76(3):123-6.

Lasithiotakis K, Grisbolaki E, Koutsomanolis D, Venianaki M, Petrakis I, Vrachassotakis N, et al. Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter. World J Surg. 2012;36(6):1286-92.

Şahin N, Uçer O. The incidence of thyroid cancer at thyroidectomy materials in Malatya. Dicle Med J. 2013;40:570-3.

Ashraf SA, Matin SA. A Review of thyroid diseases in Bangladesh. J BCPS. 1996;2(1):6-10.

Rahman MJ, Mustafa MG. Comparative study of cancer developing in Solitary thyroid nodule and multi-nodular goiter. Bangladesh Ototorhinolargygol. 2000;6(11):6-12.